Publication

Article

Digital Edition

Ophthalmology Times: July 15, 2020
Volume45
Issue 12

Diagnosing a 'down looker'

Author(s):

Jon Carter

Diagnosing a 'down looker'

Diagnosing a 'down looker'


See more Optic Relief content by Jon Carter

Download Issue PDF
Articles in this issue
Aspheric, aberration-free IOL leverages technology for performance
Aspheric, aberration-free IOL leverages technology for performance
Emerging opportunities — and risks — with telehealth in a pandemic
Emerging opportunities — and risks — with telehealth in a pandemic
Figure 1: The Tecnis Toric II lens has an edge of the haptic that is unpolished to create more friction
Toric stability: A minor change with a major impact for patients
Teaching AI algorithms to identify corneal pathology: The future is now
Teaching AI algorithms to identify corneal pathology: The future is now
Diagnosing a 'down looker'
Diagnosing a 'down looker'
A hands-free treatment regimen is found to be safe and effective compared with a conventional eyedrop regimen.
Dropless, hands-free regimen key for patients
Amid pandemic, friendly bugs can help protect the eye from infection
Amid pandemic, friendly bugs can help protect the eye from infection
(Figure 1) These images show the remaining island of residual tissue targeted by gene therapy at treatment. The image at left is 1 week after treatment. (Photos courtesy of M. Dominik Fischer, MD, PhD)
Gene therapy offers hope for choroideremia
Machine-learning algorithms could help predict course of NPDR
Machine-learning algorithms could help predict course of NPDR
Thyroid eye disease: Not limited to visual impairment
Thyroid eye disease: Not limited to visual impairment
Beating burnout with camaraderie
Beating burnout with camaraderie
Themistocles: Everyone's second chance
Themistocles: Everyone's second chance
IOP homeostasis in glaucoma: Looking below the surface
IOP homeostasis in glaucoma: Looking below the surface
Clearing hurdles to large scale telemedicine adoption
Clearing hurdles to large scale telemedicine adoption
A patient's vision loss leads to another diagnosis
The eyes offer conjunctival clue to COVID-19

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
Related Content
Lupin launches loteprednol etabonate ophthalmic suspension, 0.5%, in the United States
July 19th 2025

Lupin launches loteprednol etabonate ophthalmic suspension, 0.5%, in the United States

3 Things You Should Know About the GA Pipeline
June 4th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

Children with ADHD may be less likely to develop myopia, study suggests
July 18th 2025

Children with ADHD may be less likely to develop myopia, study suggests

Patient-Centered Treatment Strategies in the Management of nAMD and DME
May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

AAVantgarde Bio receives IND clearance for AAVB-039
July 17th 2025

AAVantgarde Bio receives IND clearance for AAVB-039

FDA accepts for review Aldeyra Therapeutics’ resubmitted New Drug Application for reproxalap
July 17th 2025

FDA accepts for review Aldeyra Therapeutics’ resubmitted New Drug Application for reproxalap

© 2025 MJH Life Sciences

All rights reserved.